Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q29005963)
Watch
Revision as of 13:40, 17 November 2023 by
Renamerr
(
talk
|
contribs
)
(
Added [uk] description:
фармацевтичний продукт,
batch #216888
)
(
diff
)
← Older revision
| Latest revision (diff) | Newer revision → (diff)
English
Imatinib Actavis
pharmaceutical product
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
pharmaceutical product
1 reference
European Medicines Agency product number
EMEA/H/C/002594
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002594/human_med_001635.jsp
retrieved
22 March 2017
mixture
1 reference
European Medicines Agency product number
EMEA/H/C/002594
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002594/human_med_001635.jsp
retrieved
22 March 2017
has active ingredient
imatinib
1 reference
European Medicines Agency product number
EMEA/H/C/002594
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002594/human_med_001635.jsp
retrieved
22 March 2017
therapeutic area
myelodysplastic/myeloproliferative neoplasm
authority
European Medicines Agency
start time
17 April 2013
1 reference
European Medicines Agency product number
EMEA/H/C/002594
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002594/human_med_001635.jsp
retrieved
16 February 2017
stated in
European Medicines Agency
dermatofibrosarcoma protuberans
authority
European Medicines Agency
start time
17 April 2013
1 reference
European Medicines Agency product number
EMEA/H/C/002594
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002594/human_med_001635.jsp
retrieved
16 February 2017
stated in
European Medicines Agency
hypereosinophilic syndrome
authority
European Medicines Agency
start time
17 April 2013
1 reference
European Medicines Agency product number
EMEA/H/C/002594
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002594/human_med_001635.jsp
retrieved
16 February 2017
stated in
European Medicines Agency
chronic myeloid leukemia
authority
European Medicines Agency
start time
17 April 2013
1 reference
European Medicines Agency product number
EMEA/H/C/002594
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002594/human_med_001635.jsp
retrieved
16 February 2017
stated in
European Medicines Agency
lymphoid leukemia
authority
European Medicines Agency
start time
17 April 2013
1 reference
European Medicines Agency product number
EMEA/H/C/002594
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002594/human_med_001635.jsp
retrieved
16 February 2017
stated in
European Medicines Agency
precursor lymphoblastic lymphoma/leukemia
authority
European Medicines Agency
start time
17 April 2013
1 reference
European Medicines Agency product number
EMEA/H/C/002594
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002594/human_med_001635.jsp
retrieved
14 July 2017
stated in
European Medicines Agency
Identifiers
European Medicines Agency product number
EMEA/H/C/002594
1 reference
European Medicines Agency product number
EMEA/H/C/002594
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002594/human_med_001635.jsp
retrieved
22 March 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
